Trial Profile
Daikenchuto (DKT) Helps Improve Postoperative Functional Gastrointestinal Disorder After Total Gastrectomy in Patients With Gastric Cancer: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2014
Price :
$35
*
At a glance
- Drugs TU 100 (Primary)
- Indications Gastric cancer; Gastrointestinal disorders; Postoperative ileus
- Focus Therapeutic Use
- 01 Oct 2014 New trial record